Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Jian-Min Yuan

Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore

Liver and intrahepatic bile ducts

Pathology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Liver and intrahepatic bile ducts

Denis Lacombe

EORTC Headquarters

Trachea, bronchus and lung Prostate Pancreas Ovary Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Leukaemia Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system

Mitchell Ho

Development of antibody-based cancer therapies

Liver and intrahepatic bile ducts

Pathology

Ahmed Kaseb

Novel Point-of-Care Tool to Predict Response to Sorafenib in Hepateocellular Carcinoma

Liver and intrahepatic bile ducts

Pathology

Jean-Francois H Geschwind

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization Drug Delivery

Liver and intrahepatic bile ducts

Pathology

Dolph Hatfield

Role of Selenium in Development and Health

Trachea, bronchus and lung Prostate Liver and intrahepatic bile ducts Colorectum

Richard T D'Aquila

Third Coast Center for AIDS Research

Trachea, bronchus and lung Non-Melanoma skin cancer Liver and intrahepatic bile ducts Leukaemia

Pathology